Skip to main content
Log in

Serum and urine levels of tumour necrosis factor in patients with genitourinary cancer and their relevance to disease status

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Serum and urine levels of tumour necrosis factor (TNF) which is a lymphokine was measured in patients with genitourinary cancer (either prostatic, bladder or testicular carcinoma) in order to find out whether there were elevated levels of TNF in those patients and if it was related to disease status.

Although the preliminary results are not conclusive, further research on TNF may prove this immunoprotein to be a potential diagnostic and therapeutic agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aggarwal, B. B., Aiyer, R. A., Pennica, D., Gray, P. W., Goeddel, D. V.: Human tumor necrosis factors: Structure and receptor interactions. In: Tumor Necrosis Factor and Related Cytotoxins. Ciba Foundation Symposium 131. Wiley and Sons Ltd., Chichester 1987.

    Google Scholar 

  2. Beutler, B., Cerami, A.: Cachectin: More than a tumor necrosis factor.N. Engl. J. Med., 316, 379 (1987).

    Article  PubMed  CAS  Google Scholar 

  3. Carswell, E., Old, L. J., Kassel, R. L., Green, S., Fiore, N., Williamson, B.: An endotoxin induced serum factor that causes necrosis of tumors.Proc. Natl. Acad. Sci., 72, 3666 (1975).

    Article  PubMed  CAS  Google Scholar 

  4. Beutler, B., Mahoney, J., LeTrang, N., Pekala, P., Cerami, A.: Purification of cachectin, a lipoprotein lipase suppressing hormone secreted by endotoxin induced RAW 264.7 cells.J. Exp. Med., 161, 984 (1985).

    Article  PubMed  CAS  Google Scholar 

  5. Palladino, M. A., Patton, J. S., Figari, I. S., Shalaby, M. R.: Possible relationships between in vivo antitumor activity and toxicity of tumor necrosis factor-alpha. In: Tumor Necrosis Factor and Related Cytotoxins. Ciba Foundation Symposium 131. Wiley and Sons Ltd., Chichester 1987.

    Google Scholar 

  6. Hass, P. E., Hotchkiss, A., Mohler, M., Aggarwal, B. B.: Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts.J. Biol. Chem., 260, 12214 (1985).

    PubMed  CAS  Google Scholar 

  7. Aggarwal, B. B., Eessalu, T. E., Hass, P. E.: Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon.Nature, 318, 665 (1985).

    Article  PubMed  CAS  Google Scholar 

  8. Shalaby, M. R., Palladino, M. R., Hirabayashi, S. E.: Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor alpha.J. Leukocyte Biol., 41, 196 (1987).

    PubMed  CAS  Google Scholar 

  9. Petersen, C. M., Moller, B. K.: Immunological reactivity of tumor necrosis factor.Lancet, 1, 935 (1988).

    Google Scholar 

  10. Sherman, M. L., Spriggs, D. R., Arthur, K. A., Imamura, K., Frei, E., Kufe, D. W.: Recombinant human tumor necrosis factor administered as a five day continuous infusion in cancer patient: Phase I toxicity and effects on lipid metabolism.J. Clin. Oncol., 6, 344 (1988).

    PubMed  CAS  Google Scholar 

  11. Ruff, M. R., Gifford, G. E.: Tumor necrosis factor. In: Pick, E. (ed.): Lymphokines. Academic Press, New York 1981; Vol. 2, 1988, p. 235.

    Google Scholar 

  12. Gifford, G. E., Flick, D. A.: Natural production and release of tumor necrosis factor. In: Tumor Necrosis Factor and Related Cytotoxins. Ciba Foundation Symposium 131. Wiley and Sons Ltd., Chichester 1987.

    Google Scholar 

  13. Ziegler, E. J.: Tumor necrosis factor in humans.N. Engl. J. Med., 318, 1533 (1988).

    Article  PubMed  CAS  Google Scholar 

  14. Tracey, K. J., Lowry, S. F., Cerami, A.: Physiological response to cachectin. In: Tumor Necrosis Factor and Related Cytotoxins. Ciba Foundation Symposium 131. Wiley and Sons Ltd., Chichester 1987.

    Google Scholar 

  15. Nawroth, P. P., Bank, I., handley, D., Cassimeris, J., Ckess, L., Stern, D.: Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.J. Exp. Med., 163, 1363 (1986).

    Article  PubMed  CAS  Google Scholar 

  16. Michie, H. R., Manogue, K. R., Spriggs, D. R.: Detection of circulating tumor necrosis factor after endotoxin administration.N. Engl. J. Med., 318, 1481 (1988).

    Article  PubMed  CAS  Google Scholar 

  17. Scuderi, P., Lam, K. S., Ryan, K. J.: Raised serum levels of tumor necrosis factor in parasitic infections.Lancet, 2, 1364 (1986).

    Article  PubMed  CAS  Google Scholar 

  18. Flick, D. A., Gifford, G. E.: Pharmacokinetic of murine tumor necrosis factor.J. Immunopharmacol., 8, 89 (1986).

    PubMed  CAS  Google Scholar 

  19. Haranaka, K., Satomi, N., Sakurai, A., Haranaka, R.: Antitumor effects of tumor necrosis factor: Cytotoxic or necrotizing activity and its mechanism. In: Tumor Necrosis Factor and Related Cytotoxins. Ciba Foundation Symposium 131. Wiley and Sons Ltd., Chichester 1987.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akdaş, A., Türkeri, L. & Akoĝlu, T. Serum and urine levels of tumour necrosis factor in patients with genitourinary cancer and their relevance to disease status. International Urology and Nephrology 22, 501–506 (1990). https://doi.org/10.1007/BF02549736

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02549736

Keywords

Navigation